Dr. Olga Petrauskene, Ph.D., MBA
Chief Operations Officer @ Diagnostic BioSystems
About
An accomplished life science business development leader with deep experience from research through commercialization in molecular diagnostics. Results-driven leader with 25 years of experience in strategic planning, cross-functional leadership, and operational excellence. Expert in IVD certification, corporate partnerships and collaborations. 2003-2004: Chair of the Applied Biosystems' Scientific Advisory Council. My primary role at Diagnostic BioSystems is driving commercial and operational excellence with focus on market demand, product design, development as well as commercialization of IVD systems and delivering revenue growth with innovative tools in the molecular diagnostics industry. Main interests are in development of innovative molecular diagnostics solutions, progressive business opportunities and building effective partnerships.
United States
Pleasanton
Biotechnology
Genomics, Molecular Biology, Technology Transfer, Product Development, Biotechnology, Lifesciences, Assay Development, Medical Devices, Commercialization, R&D, Molecular Diagnostics, DNA, Science, qPCR, Cross-functional Team Leadership, Start-ups, DNA sequencing, Oncology, Strategy, Protein Chemistry
Experience

Chief Operations Officer
Pleasanton, California, United States
As a Chief Operations Officer at Diagnostic BioSystems , I am responsible for driving excellence in operations, strategic marketing and sales, as well as establishing corporate partnerships, defining new strategic developments, strengthen manufacturing and improving corporate quality system.

General Manager & VP of Buiness Development
Pleasanton, California
My role as General Manager & VP of Buiness Development at Diagnostic BioSystems includes driving strategic marketing and sales, strengthening corporate partnerships, defining new strategic developments and improving quality system.

President and CEO
Stanford
Molecular Decisions creates highly innovative, unique and rapid diagnostic solutions for efficient drug development and personalized treatment. The goal of the company is to develop tests for use by hospitals and diagnostics labs that determine immediately whether chemotherapy is working or has to be changed. It currently takes about three months to obtain similar results. Since chemotherapy is toxic, this is a critical improvement that can save lives and reduce needless suffering and degradation. Molecular Decisions provides services to pharmaceutical companies, helping them do faster and more confident drug development and clinical trials. https://www.molecular-decisions.com/
Education
Dr. Olga Petrauskene, Ph.D., MBA's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.











